Spectral Diagnostics - 24 Year Stock Price History | EDTXF
Historical daily share price chart and data for Spectral Diagnostics since 2001 adjusted for splits and dividends. The latest closing stock price for Spectral Diagnostics as of May 02, 2025 is 0.57.
- The all-time high Spectral Diagnostics stock closing price was 2.55 on February 19, 2004.
- The Spectral Diagnostics 52-week high stock price is 0.61, which is 7% above the current share price.
- The Spectral Diagnostics 52-week low stock price is 0.32, which is 43.9% below the current share price.
- The average Spectral Diagnostics stock price for the last 52 weeks is 0.43.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Spectral Diagnostics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
0.4670 |
0.3470 |
0.5900 |
0.3400 |
0.5721 |
64.87% |
| 2024 |
0.3924 |
0.3390 |
0.5330 |
0.2970 |
0.3470 |
8.44% |
| 2023 |
0.2481 |
0.2760 |
0.3200 |
0.1840 |
0.3200 |
19.40% |
| 2022 |
0.2852 |
0.1760 |
0.4370 |
0.1760 |
0.2680 |
52.27% |
| 2021 |
0.3356 |
0.3200 |
0.5900 |
0.1660 |
0.1760 |
-44.65% |
| 2020 |
0.4086 |
0.6005 |
0.6379 |
0.2700 |
0.3180 |
-44.21% |
| 2019 |
0.3327 |
0.1950 |
0.5922 |
0.1950 |
0.5700 |
184.86% |
| 2018 |
0.2540 |
0.3380 |
0.3380 |
0.1793 |
0.2001 |
-37.47% |
| 2017 |
0.3074 |
0.2200 |
0.4470 |
0.1800 |
0.3200 |
45.45% |
| 2016 |
0.5978 |
0.5770 |
1.4500 |
0.1362 |
0.2200 |
-62.07% |
| 2015 |
0.5975 |
0.2788 |
0.9210 |
0.2388 |
0.5800 |
99.31% |
| 2014 |
0.3306 |
0.5588 |
0.5887 |
0.2093 |
0.2910 |
-47.09% |
| 2013 |
0.3922 |
0.2700 |
0.7000 |
0.1810 |
0.5500 |
109.92% |
| 2012 |
0.2383 |
0.2560 |
0.2972 |
0.1840 |
0.2620 |
24.76% |
| 2011 |
0.2711 |
0.3111 |
0.3700 |
0.1835 |
0.2100 |
-40.86% |
| 2010 |
0.4545 |
0.7335 |
0.7335 |
0.3066 |
0.3551 |
-31.71% |
| 2009 |
0.3031 |
0.2770 |
0.5200 |
0.1200 |
0.5200 |
225.61% |
| 2008 |
0.3529 |
0.4583 |
0.7525 |
0.1038 |
0.1597 |
-62.37% |
| 2007 |
0.6622 |
0.6880 |
1.0550 |
0.4004 |
0.4244 |
-39.26% |
| 2006 |
0.4108 |
0.3600 |
0.6987 |
0.2620 |
0.6987 |
105.50% |
| 2005 |
0.4773 |
0.8600 |
0.8780 |
0.2750 |
0.3400 |
-63.24% |
| 2004 |
1.5330 |
1.8600 |
2.5500 |
0.8400 |
0.9250 |
-50.93% |
| 2003 |
1.4912 |
1.0000 |
2.4200 |
0.5700 |
1.8850 |
106.01% |
| 2002 |
1.1484 |
0.8500 |
1.6300 |
0.7600 |
0.9150 |
12.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.163B |
$0.002B |
|
Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada.
|
